Q4 2024 · 13F-HR
TYNDALL CAPITAL PARTNERS L Pholdings as filed
Filed 2025-02-14 · accession 0001493152-25-006832
$530,582
Reported value
1
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23255M204 | CYCN | CYCLERION THERAPEUTICS INC | $530,582 | 100.0% | 164,777 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.